Johannes Birtel, Alnylam Pharmaceuticals (C), Heidelberg Engineering (F);
Martin Gliem, F. Hoffmann-La Roche (E), F. Hoffmann-La Roche (I), Heidelberg Engineering (F);
Kristina Hess, Heidelberg Engineering (F);
Theresa Birtel, Heidelberg Engineering (F);
Frank G. Holz, Acucela (C), Acucela (F), Acucela (R), Allergan (F), Allergan (R), Appelis (C), Appelis (R), Bayer (C), Bayer (F), Bayer (R), Bioeq/Formycon (C), Bioeq/Formycon (F), Boehringer-Ingelheim (C), CenterVue (F), Grayburg Vision (C), Grayburg Vision (R), Heidelberg Engineering (C), Heidelberg Engineering (F), Heidelberg Engineering (R), Novartis (C), Novartis (F), Novartis (R), Roche/Genentech (C), Roche/Genentech (F), Roche/Genentech (R);
Ulrich Zechner, None;
Hanno Bolz, None;
Philipp Herrmann, Heidelberg Engineering (F)